Valeo Financial Advisors, LLC Genmab A/S Transaction History

Valeo Financial Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 28, 2020	SELL	$33.07 - $38.68 $1,554 - $1,817	-47 Closed	0 $0
Q2 2020 Jul 20, 2020	SELL	$20.05 - $33.89 $601 - $1,016	-30 Reduced 38.96%	47 $2,000
Q1 2020 Apr 13, 2020	BUY	$17.15 - $25.22 $428 - $630	25 Added 48.08%	77 $2,000
Q4 2019 Jan 24, 2020	BUY	$18.88 - $24.14 $981 - $1,255	52 New	52 $1,000

236

52.5M

10.2K

25.5K

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.